By Susan Heavey
(Reuters) – An epilepsy drug also used to help prevent migraines can increase the risk for oral birth defects in babies born to women taking the medication, health officials said on Friday.
The Food and Drug Administration said new data shows expecting mothers taking the drug, sold generically and as Johnson & Johnson’s Topamax, are about 20 times more likely to have their infants develop cleft lips or cleft palate deformities than those who are not treated.
Read the Full Article Here: http://www.reuters.com/article/2011/03/04/us-migraine-birthdefects-idUSTRE7233RR20110304
Published on March 16, 2011